Bionano Genomics Files Q1 2025 10-Q
Ticker: BNGO · Form: 10-Q · Filed: May 14, 2025 · CIK: 1411690
| Field | Detail |
|---|---|
| Company | Bionano Genomics, Inc. (BNGO) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Bionano Genomics dropped its Q1 2025 10-Q, check financials.
AI Summary
Bionano Genomics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the laboratory analytical instruments sector.
Why It Matters
This filing provides investors and stakeholders with the latest financial and operational data for Bionano Genomics, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a publicly traded company in the biotechnology sector, Bionano Genomics faces inherent risks related to market volatility, regulatory changes, and competitive pressures.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of 2025)
- 12-31 — Fiscal Year End (Company's fiscal year closes on December 31st)
Key Players & Entities
- Bionano Genomics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250514 (date) — Filing date
- SAN DIEGO, CA (location) — Company headquarters
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
What is the Standard Industrial Classification for Bionano Genomics, Inc.?
The Standard Industrial Classification for Bionano Genomics, Inc. is LABORATORY ANALYTICAL INSTRUMENTS [3826].
What is the company's business address?
The company's business address is 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121.
What is the company's fiscal year end?
The company's fiscal year end is December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Bionano Genomics, Inc. (BNGO).